Stock Track | Orthofix International Plummets 5% Intraday on Disappointing Q4 Earnings

Stock Track

Feb 26, 2025

Orthofix International NV shares plummeted 5.01% during Tuesday's intraday trading session, as the medical device maker's disappointing fourth-quarter earnings report weighed heavily on investor sentiment.

For the quarter ended December 2024, Orthofix reported earnings per share of $0.02, missing the consensus estimate of $0.06 per share. However, the company's revenue of $215.66 million surpassed expectations of $212.63 million. The earnings miss was a major disappointment for investors, despite the revenue beat.

Looking ahead, Orthofix expects full-year revenue for 2025 to range between $818 million and $826 million. Investors will closely monitor the company's performance and guidance in the coming quarters to assess its ability to regain profitability and deliver consistent earnings growth.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/1158201370"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1158201370\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1158201370?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-02-26 00:28","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1158201370","market":"us","top_or_hot":-1,"title":"Stock Track | Orthofix International Plummets 5% Intraday on Disappointing Q4 Earnings","media":"Stock Track","content":"<p>Orthofix International NV shares plummeted 5.01% during Tuesday's intraday trading session, as the medical device maker's disappointing fourth-quarter earnings report weighed heavily on investor sentiment.</p>\n\n<p>For the quarter ended December 2024, Orthofix reported earnings per share of $0.02, missing the consensus estimate of $0.06 per share. However, the company's revenue of $215.66 million surpassed expectations of $212.63 million. The earnings miss was a major disappointment for investors, despite the revenue beat.</p>\n\n<p>Looking ahead, Orthofix expects full-year revenue for 2025 to range between $818 million and $826 million. Investors will closely monitor the company's performance and guidance in the coming quarters to assess its ability to regain profitability and deliver consistent earnings growth.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Orthofix International Plummets 5% Intraday on Disappointing Q4 Earnings</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Orthofix International Plummets 5% Intraday on Disappointing Q4 Earnings\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2025-02-26 00:28</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Orthofix International NV shares plummeted 5.01% during Tuesday's intraday trading session, as the medical device maker's disappointing fourth-quarter earnings report weighed heavily on investor sentiment.</p>\n\n<p>For the quarter ended December 2024, Orthofix reported earnings per share of $0.02, missing the consensus estimate of $0.06 per share. However, the company's revenue of $215.66 million surpassed expectations of $212.63 million. The earnings miss was a major disappointment for investors, despite the revenue beat.</p>\n\n<p>Looking ahead, Orthofix expects full-year revenue for 2025 to range between $818 million and $826 million. Investors will closely monitor the company's performance and guidance in the coming quarters to assess its ability to regain profitability and deliver consistent earnings growth.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"OFIX","symbol_name":"Orthofix International N.V.","start_time":0,"source_url":"","article_id":"1158201370","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1158201370","pubTimestamp":1740500931,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Orthofix International NV shares plummeted 5.01% during Tuesday's intraday trading session, as the medical device maker's disappointing fourth-quarter earnings report weighed heavily on investor sentiment.For the quarter ended December 2024, Orthofix reported earnings per share of $0.02, missing the consensus estimate of $0.06 per share. However, the company's revenue of $215.66 million surpassed expectations of $212.63 million. The earnings miss was a major disappointment for investors, despite","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"OFIX":"Orthofix International N.V."},"translate_title":"股票追踪Orthofix International因第四季度盈利令人失望而盘中暴跌5%","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"OFIX":1},"content_text":"Orthofix International NV shares plummeted 5.01% during Tuesday's intraday trading session, as the medical device maker's disappointing fourth-quarter earnings report weighed heavily on investor sentiment.\nFor the quarter ended December 2024, Orthofix reported earnings per share of $0.02, missing the consensus estimate of $0.06 per share. However, the company's revenue of $215.66 million surpassed expectations of $212.63 million. The earnings miss was a major disappointment for investors, despite the revenue beat.\nLooking ahead, Orthofix expects full-year revenue for 2025 to range between $818 million and $826 million. Investors will closely monitor the company's performance and guidance in the coming quarters to assess its ability to regain profitability and deliver consistent earnings growth.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}